Analyst Research

Report Title Price
Provider: Pechala's Reports
Provider: Pechala's Reports
Provider: MacroRisk Analytics/EconomicInvestor
Provider: Ratings

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Tianyin Pharmaceutical Co Inc Reiterates FY 2013 Revenue Guidance

Thursday, 14 Feb 2013 05:55am EST 

Tianyin Pharmaceutical Co Inc reiterated its fiscal 2013 revenue projection of approximately $75 million to $80 million. 

Latest Key Developments in Pharmaceuticals

Company Quote

-0.02 -3.08%
11 Jul 2014